Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
03/2012
03/15/2012WO2012034025A2 Human cytomegalovirus vaccine
03/15/2012WO2012033382A2 Novel rna-binding protein and label-free detection method for detecting microrna using same
03/15/2012WO2012033268A1 Peptide having the ability to regenerate bone tissue and for binding to apatite
03/15/2012WO2011137243A3 Fluorescent fusion polypeptides and methods of use
03/15/2012US20120065385 Dendritic cell co-stimulatory molecules
03/15/2012US20120065380 Dual targeting antibody of novel form, and use thereof
03/15/2012US20120065374 Dendritic cell co-stimulatory molecules
03/15/2012US20120065134 Cd40-l inhibitory phylomer peptides
03/15/2012US20120065123 Synthetic Antibodies
03/15/2012US20120064600 Anti-5t4 antibodies and uses thereof
03/15/2012US20120064593 Superantibody synthesis and use in detection, prevention and treatment of disease
03/15/2012US20120064578 Chromosome-based platforms
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064543 Method for detecting substance in biological sample
03/15/2012US20120064106 Flagellin fusion proteins and use thereof to induce immune responses against pseudomonas aeruginosa
03/15/2012US20120064076 Methods and composition to regulate iron metabolism
03/15/2012US20120063994 Rtef-1 variants and uses thereof
03/15/2012CA2811621A1 Peptide having the ability to regenerate bone tissue and for binding to apatite
03/14/2012EP1436003B3 Taci-immunoglobulin fusion proteins
03/14/2012CN1558774B Angiotensin peptide-carrier conjugates and uses thereof
03/14/2012CN102373234A Method for purifying recombinant proteins with intein-mediated elastin like proteins
03/14/2012CN102372782A Insect antibacterial peptide diapause specific peptide (DSP) fusion protein and application thereof to plant disease resistance
03/14/2012CN102372781A Insect antibacterial peptide thanatin (s) fusion protein and application thereof to plant disease resistance
03/14/2012CN102372780A Preparation method and application of anti-human chorionic gonadotropin (hCG) antibody-interleukin 2 (IL2) fusion protein
03/14/2012CN102372766A O-type foot-and-mouth disease multi-epitope vaccine with cross immunity protective efficiency
03/14/2012CN102370979A Building method for autovaccine by aiming at human TNF(Tumor Necrosis Factor)-alpha molecule
03/14/2012CN102370976A Mixed virus-like particles of swine influenza virus and foot and mouth disease virus, preparation method and application thereof
03/14/2012CN102370974A Yeast-based vaccines as immunotherapy
03/13/2012US8133866 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
03/13/2012CA2356779C Cytokine receptor chain
03/13/2012CA2238080C A novel haemopoietin receptor and genetic sequences encoding same
03/13/2012CA2223716C A method for promoting enzyme diversity
03/13/2012CA2199049C Novel pesticidal proteins and strains
03/08/2012WO2012031258A1 Recombinant t-cell receptor ligands with covalently bound peptides
03/08/2012WO2012030735A1 Method and composition for crystallizing a family c gpcr
03/08/2012WO2012027850A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012WO2011126811A3 High level expression of recombinant toxin proteins
03/08/2012US20120058953 Compositions and methods for enhancing apoptosis
03/08/2012US20120058344 Electronic Devices with Protein Layers
03/08/2012US20120058143 Staphylococcus aureus proteins and nucleic acids
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058116 Fgfr1c antibody combinations
03/08/2012US20120058114 ERBB2 antibodies comprising modular recognition domains
03/08/2012CA2809890A1 Peptide containing multiple n-linked glycosylation sequons
03/07/2012EP2424898A1 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
03/07/2012EP1348029B1 Materials and methods relating to protein aggregation in neurodegenerative disease
03/07/2012CN102369284A Polypeptides having cellulase activity
03/07/2012CN102369220A Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof
03/07/2012CN102369218A Anti-fcrh5 antibodies and immunoconjugates and methods of use
03/07/2012CN102367453A Experimental technique for recombinant fusion protein (VEGF121-FC) of human vascularendothelial growth factor (VEGF) 121 and immunoglobulin Fc fragment
03/07/2012CN102367278A Method for cultivating disease-resisting wheat and special recombinant plasmid thereof
03/07/2012CN102367277A Polymer conjugates of mutated neublastin
03/07/2012CN102020716B Gene recombination human collagen fusion peptide segment, preparation method and application thereof
03/06/2012US8129331 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
03/06/2012US8128926 Sp35 antibodies and uses thereof
03/06/2012CA2290944C Pgc-1, a novel brown fat ppar.gamma. coactivator
03/06/2012CA2253924C Vasoactive amine binding molecules
03/01/2012WO2011136506A9 Method for producing recombinant complex antigens using nanoparticles of human rotavirus
03/01/2012WO2011133493A3 Allosteric regulation of kinase activity
03/01/2012WO2011119628A3 Compositions and methods for self-adjuvanting vaccines against microbes and tumors
03/01/2012WO2011113027A3 Npp1 fusion proteins
03/01/2012US20120053325 Purification of Immunoglobulins
03/01/2012US20120053321 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods
03/01/2012US20120053129 Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof
03/01/2012US20120052569 Tag peptide having a protease recognition sequence and use thereof
03/01/2012US20120052084 Staphylococcus aureus proteins and nucleic acids
03/01/2012US20120052069 Fgf21 mutants and uses thereof
03/01/2012US20120052068 Autophilic antibodies and method of making the same
03/01/2012CA2809029A1 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/01/2012CA2808539A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
02/2012
02/29/2012EP2423233A2 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same
02/29/2012EP2422807A2 Hybrid polypeptides with selectable properties
02/29/2012EP2422806A2 Hybrid polypeptides with selectable properties
02/29/2012EP2421901A2 Compositions containing hc ha complex and methods of use thereof
02/29/2012EP2421611A1 Fgfr1c antibody combinations
02/29/2012EP2421557A1 A tuberculosis tb vaccine to prevent reactivation
02/29/2012EP1325133B1 Bvh-a2 and bvh-a3 antigens of group b streptococcus
02/29/2012CN1884301B Targeted function superantigen and its preparation method and use
02/29/2012CN101121754B Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes
02/28/2012US8124750 Recombinant protective protein from Streptococcus pneumoniae
02/28/2012US8124378 Murine zcytor17 ligand polynucleotides
02/28/2012US8124356 Methods of purifying zsig33
02/28/2012US8124066 Methods of using interleukin-2 mutants with reduced toxicity
02/28/2012CA2392202C Constructs for delivery of therapeutic agents to neuronal cells
02/23/2012WO2012024558A2 Light mediated regulation of protein dimerization
02/23/2012WO2012023838A2 Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same
02/23/2012WO2012023580A1 Method for producing low immunogenic streptavidin having antibody bonded thereto
02/23/2012WO2012023579A1 Process for production of streptavidin
02/23/2012WO2012023290A1 Rasef as tumor marker and therapeutic target for cancer
02/23/2012WO2012022495A1 Oncolytic measles virus
02/23/2012WO2011123683A3 Protease activated cytokines
02/23/2012US20120046221 Albumin fusion proteins
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor
02/22/2012EP2420242A1 Oncolytic measles virus
02/22/2012EP2419515A2 Polypeptides having cellulase activity
02/22/2012EP2419512A1 Method of screening for insulin secretion-potentiating agents
02/22/2012EP2419444A1 Therapeutic antennapedia-antibody molecules and methods of use thereof
02/22/2012CN1642976B 一种突变的免疫球蛋白-结合蛋白 A mutant immunoglobulin - binding protein
02/22/2012CN102361979A Peptide capable of binding to immunoglobulin
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 295